Yoshida et al. found that treatment with recombinant human FGF2 and deproteinized bovine bone mineral clearly improved probing pocket depth and clinical attachment in the patients with chronic periodontitis [34]. This evidence concerns the gene FGF2 and chronic periodontitis.